Relationships between Structure and Interaction Kinetics for HIV-1 Protease Inhibitors

Journal of Medicinal Chemistry
2002.0

Abstract

The interaction between HIV-1 protease and 58 structurally diverse transition-state analogue inhibitors has been analyzed by a surface plasmon resonance based biosensor. Association and dissociation rate constants and affinities were determined and displayed as k(on)-k(off)-K(D) maps. It was shown that different classes of inhibitors fall into distinct clusters in these maps. Significant changes in association and dissociation rates were found as a result of modifying the P1/P1' or P2/P2' side chains of a linear lead compound. Similarly, cyclic urea and cyclic sulfamide inhibitors displayed different kinetic features and the affinities of both classes of cyclic compounds were limited by fast dissociation rates. These results confirm that association and dissociation rates are important features of drug-target interactions and indicate that optimization of inhibitor efficacy may be guided by aiming for high association and low dissociation rates rather than high affinity alone. The present approach thus provides a new tool for structure-interaction kinetic analysis and drug discovery.

Knowledge Graph

Similar Paper

Relationships between Structure and Interaction Kinetics for HIV-1 Protease Inhibitors
Journal of Medicinal Chemistry 2002.0
Improved Structure−Activity Relationship Analysis of HIV-1 Protease Inhibitors Using Interaction Kinetic Data
Journal of Medicinal Chemistry 2004.0
Introduction of Intrinsic Kinetics of Protein–Ligand Interactions and Their Implications for Drug Design
Journal of Medicinal Chemistry 2018.0
Experimental and ‘in silico’ analysis of the effect of pH on HIV-1 protease inhibitor affinity: Implications for the charge state of the protein ionogenic groups
Bioorganic & Medicinal Chemistry 2012.0
Protein–ligand (un)binding kinetics as a new paradigm for drug discovery at the crossroad between experiments and modelling
MedChemComm 2017.0
Cyclic HIV Protease Inhibitors:  Synthesis, Conformational Analysis, P2/P2‘ Structure−Activity Relationship, and Molecular Recognition of Cyclic Ureas
Journal of Medicinal Chemistry 1996.0
Identification of Weak Points of Hepatitis C Virus NS3 Protease Inhibitors Using Surface Plasmon Resonance Biosensor-Based Interaction Kinetic Analysis and Genetic Variants
Journal of Medicinal Chemistry 2014.0
Additional level of information about complex interaction between non-nucleoside inhibitor and HIV-1 reverse transcriptase using biosensor-based thermodynamic analysis
Bioorganic & Medicinal Chemistry 2007.0
Early Absorption and Distribution Analysis of Antitumor and Anti-AIDS Drugs:  Lipid Membrane and Plasma Protein Interactions
Journal of Medicinal Chemistry 2005.0
Cyclic HIV-1 Protease Inhibitors Derived from Mannitol:  Synthesis, Inhibitory Potencies, and Computational Predictions of Binding Affinities
Journal of Medicinal Chemistry 1997.0